Paradigm Biopharmaceuticals (ASX: $PAR) released positive progression on study updates for March 2020 quarter, with Cash position as at 31st March 2020 of $74.5m, opened and finished high with more than 12% gain today. https://t.co/7SwffuOLTh. #biopharma #quarterlyresult #stocks https://t.co/d7brarDNZi